Professor of Surgery Director Pediatric Transplantation Research Co-Dir Ped Abdominal Transplant
General Surgery
Dr. Rakesh K. Sindhi, MD
|
|
Give Review
Rakesh Sindhi works in the field of General Surgery. He went to medical school at University of Nebraska Medical Center. University of Nebraska Medical Center is one of the top medical schools in the US. University of Nebraska Medical Center is ranked 60 in research and 4 in primary care medicine He received 1 awards: "Fellow (FACS)". Rakesh K. Sindhi has written publications. He has 101 publications published with PubMed. The lastest publication is: 'Duodenal segment complications in vascularized pancreas transplantation.'
Publications
- Profile of the Pleximmune blood test for transplant rejection risk prediction.
- Liver allograft fibrosis and minimization of immunosuppression.
- The challenges of Liver transplantation in children with primary sclerosing cholangitis.
- Analysis of national and single-center incidence and survival after Liver transplantation for hepatoblastoma: new trends and future opportunities.
- Right diaphragmatic hernia after Liver transplant in pediatrics: A case report and review of the literature.
- Mucosal plasma cell barrier disruption during intestine transplant rejection.
- Late graft loss or death in pediatric Liver transplantation: an analysis of the SPLIT database.
- De novo malignancies after intestinal and multivisceral transplantation.
- Current perspectives on pediatric intestinal transplantation.
- Chronic high Epstein-Barr viral load carriage in pediatric small bowel transplant recipients.
- Elevated myeloid: plasmacytoid dendritic cell ratio associates with early acute cellular rejection in pediatric small bowel transplantation.
- Lymphoproliferative disorders and de novo malignancies in intestinal and multivisceral recipients: improved outcomes with new outlooks.
- Five hundred intestinal and multivisceral transplantations at a single center: major advances with new challenges.
- Elevated myeloid: plasmacytoid dendritic cell ratio associates with late, but not early, Liver rejection in children induced with rabbit anti-human thymocyte globulin.
- Proliferative alloresponse of T-cytotoxic cells identifies rejection-prone children with steroid-free Liver transplantation.
- Allospecific CD154+ T cells identify rejection-prone recipients after pediatric small-bowel transplantation.
- Pediatric intestinal retransplantation: techniques, management, and outcomes.
- Allospecific CD154+ T cells associate with rejection risk after pediatric Liver transplantation.
- Lymphocyte subset reconstitution in pediatric Liver recipients induced with steroid-free rabbit anti-human thymocyte globulin.
- Evolution of the immunosuppressive strategies for the intestinal and multivisceral recipients with special reference to allograft immunity and achievement of partial t...
- Lymphocyte subset reconstitution patterns in children with small bowel transplantation induced with steroid-free rabbit anti-human thymocyte globulin.
- Genetic variants in major histocompatibility complex-linked genes associate with pediatric Liver transplant rejection.
- Long term management of Liver transplant rejection in children.
- Increased Monocyte Expression of Sialoadhesin During Acute Cellular Rejection and Other Enteritides After Intestine Transplantation in Children.
- Allospecific CD154 + T-cytotoxic memory cells as potential surrogate for rejection risk in pediatric intestine transplantation.
- Current status of pediatric intestinal failure, rehabilitation, and transplantation: summary of a colloquium.
- Increased expression of peripheral blood leukocyte genes implicate CD14+ tissue macrophages in cellular intestine allograft rejection.
- Cellular alloresponses for rejection-risk assessment after pediatric transplantation.
- Liver transplantation for classical maple syrup urine disease: long-term follow-up in 37 patients and comparative United Network for Organ Sharing experience.
- Allospecific CD154+ T-cytotoxic memory cells identify recipients experiencing acute cellular rejection after renal transplantation.
- Intestinal transplantation in children: a review of immunotherapy regimens.
- Growth pre- and postimplementation of a steroid-free induction protocol in a large pediatric intestinal transplant population.
- One thousand consecutive primary Liver transplants under tacrolimus immunosuppression: a 17- to 20-year longitudinal follow-up.
- NOD2 gene polymorphism rs2066844 associates with need for combined Liver-intestine transplantation in children with short-gut syndrome.
- Allospecific CD154+ B cells associate with intestine allograft rejection in children.
- Modified "Liver-sparing" multivisceral transplant with preserved native spleen, pancreas, and duodenum: technique and long-term outcome.
- Review of outcomes of primary Liver cancers in children: our institutional experience with resection and transplantation.
- Immune monitoring in small bowel transplantation.
- Proliferative alloresponse of T cytotoxic cells identifies rejection-prone children with small bowel transplantation.
- Pediatric small bowel transplantation.
- PELD allocation and acute Liver/graft failure.
- Clinical tolerance following Liver transplantation: long term results and future prospects.
- HSV infection and immunosuppression.
- Persistent donor-specific alloreactivity may portend delayed Liver rejection during drug minimization in children.
- Sirolimus pharmacokinetic differences between children and adults.
- Isolated Liver transplantation in infants with short gut syndrome: is less better?
- Pancreatic transplantation at the University of Pittsburgh.
- Elective Liver transplantation for the treatment of classical maple syrup urine disease.
- Individualizing combination of two antiproliferative immunosuppressants with pharmacodynamic modeling of stimulated lymphocyte responses.
- Replacing calcineurin inhibitors with mTOR inhibitors in children.
- Intestinal transplantation under tacrolimus monotherapy after perioperative lymphoid depletion with rabbit anti-thymocyte globulin (thymoglobulin).
- Evolutionary experience with immunosuppression in pediatric intestinal transplantation.
- Immunosuppressant strategies for intestinal transplantation: a review of a tolerogenic regimen.
- Carcinoma of donor origin after Liver-intestine transplantation in a child.
- Sclerosing peritonitis after intestinal transplantation in children.
- Reduced immunosuppression in pediatric Liver-intestine transplant recipients with CD8+CD28- T-suppressor cells.
- Enhanced donor-specific alloreactivity occurs independently of immunosuppression in children with early Liver rejection.
- Transient posttransplant graft-versus-host lymphadenopathy.
- Graft versus host disease in intestinal transplantation.
- Pharmacokinetics of sirolimus and tacrolimus in pediatric transplant patients.
- Multiparametric effect: concentration analyses.
- Lymphocyte subsets may discern treatment effects in children and young adults with post-transplant lymphoproliferative disorder.
- Preventing acute and chronic rejection after diagnosis of post-transplantation lymphoproliferative disorder.
- Liver transplantation in children with cystic fibrosis: a long-term longitudinal review of a single center's experience.
- Liver and intestinal transplantation in a child with cystic fibrosis: a case report.
- Sirolimus in pediatric transplant recipients.
- Modeling individual variation in biomarker response to combination immunosuppression with stimulated lymphocyte responses-potential clinical implications.
- Causes of mortality beyond 1 year after primary pediatric Liver transplant under tacrolimus.
- Posttransplant lymphoproliferative disorders in Liver transplantation: a 20-year experience.
- Preliminary immunosuppression withdrawal strategies with sirolimus in children with Liver transplants.
- Pharmacodynamics of sirolimus in transplanted children receiving tacrolimus.
- Rituximab in the treatment of pediatric small bowel transplant patients with posttransplant lymphoproliferative disorder unresponsive to standard treatment.
- Sirolimus for rescue and primary immunosuppression in transplanted children receiving tacrolimus.
- Clinical intestinal transplantation: a decade of experience at a single center.
- Cytokines and cell surface receptors as target end points of immunosuppression with cyclosporine A.
- Phase III trial of Rapamune versus placebo in primary renal allograft recipients.
- Stimulated response of peripheral lymphocytes may distinguish cyclosporine effect in renal transplant recipients receiving a cyclosporine+rapamycin regimen.
- Split-Liver transplantation: a comparison of ex vivo and in situ techniques.
- Impact of segmental grafts on pediatric Liver transplantation--a review of the United Network for Organ Sharing Scientific Registry data (1990-1996).
- Duodenal segment complications in vascularized pancreas transplantation.
- Factor V inhibitor in a Liver transplant patient associated with porcine xenoperfusion.
- Abbreviating area under the curves further: a practical approach to monitoring extended pharmacokinetics with Neoral.
- The first 50 pancreas transplants in South Carolina.
- Retransplantation in the diabetic with a pancreas allograft after previous kidney or pancreas transplant.
- Bench reconstruction of pancreas for transplantation: experience with 192 cases.
- Experience with enteric conversion after pancreatic transplantation with bladder drainage.
- Solitary pancreas transplantation. Experience with 62 consecutive cases.
- Analysis of early readmissions after combined pancreas-kidney transplantation.
- Combined Liver/small bowel transplantation using a blood group compatible but nonidentical donor.
- Humoral graft-versus-host disease after pancreas transplantation with an ABO-compatible and Rh-nonidentical donor. Case report and a rationale for preoperative screening.
- FK 506 induction and rescue therapy in pancreas transplant recipients.
- A prospective randomized trial of OKT3 vs ATGAM induction therapy in pancreas transplant recipients.
- Experience with protocol biopsies after solitary pancreas transplantation.
- Is there a transfusion effect in combined pancreas-kidney transplantation?
- Diagnosis and treatment of symptomatic peripancreatic fluid collections after pancreas transplant.
- Preliminary experience with FK 506 in pancreas transplant recipients.
- Solitary pancreas transplantation: experience with 50 consecutive cases.
- Experience with pancreas retransplantation.
- Infection prophylaxis in pancreas transplant recipients.
- Increased risk of pulmonary edema in diabetic patients undergoing preemptive pancreas transplantation with OKT3 induction.
Procedures Preformed
- Liver Transplant
- Peripheral Artery Catheterization
Conditions Treated
- Biliary Atresia
- Liver Cancer
Doctors Specialties
- General Surgery
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Cross Blue Shield
- Cigna HMO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Coventry Health America PPO
- First Health (Coventry Health Care) PPO
- Golden Rule
- Harvard Pilgrim Health Care PPO
- HealthSmart
- Community Blue PPO
- Choice Care PPO
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Passport Health Plan
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
- UPMC PPO
- Wells Fargo Insurance
Awards
- Fellow (FACS)
Education
-
University of Nebraska Medical Center -
Tufts Medical Center -
Lincoln Medical and Mental Health Center -
Armed Forces Medical College Pune
Hospital
-
UPMC Presbyterian Shadyside
Helpful Reviews
Similar Doctors
|
|
Dr. Marc D. Liang, MD |
|
Dr. James P. Celebrezze Jr., MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Melissa E. Hogg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Garth A. Elias, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew R. Rosengart, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shannon C. Fraser, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anita P. Courcoulas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Norman Wolmark, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ward M. Richardson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marco Zenati, MD |
|
|
Dr. Paul D. Bianculli, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joshua B. Brown, MD |
|
|
Dr. Elizabeth R. Johnson, MD |
|
|
Dr. Ralitsa T. Loewen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Abolhassan Panahandeh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Patrick R. Varley, MD
This Doctor is OpenDoctor Recommended.
|